Mooradian A D, Morley J E, Korchik W K, Ma D, Shafer R B
Eur J Nucl Med. 1983;8(11):495-8. doi: 10.1007/BF00598909.
In vitro thyroid function tests were studied in 30 patients on regular hemodialysis. In addition, 8 patients (one not yet dialyzed) underwent perchlorate discharge testing and the salivary to plasma ratio of 131I was measured to identify defects in iodine uptake or organification. When compared with 35 healthy controls, uremic patients had lower total T4 (5.8 +/- 0.4 vs 8.6 +/- 0.3 micrograms/100 ml) and total T3 (81 +/- 6 vs 124 +/- 5 ng/100 ml) but T3RU was higher in dialysis patients (35.5 +/- 0.9 vs 28 +/- 0.5%, P less than 0.01). The TSH levels were not different from those of controls. The RAI uptake 1 h after perchlorate was significantly higher than the control valve (0.6 +/- 0.14 vs 0.06 +/- 0.04, P less than 0.05). Similarly, the salivary to plasma ratio of 131I was higher in patients with chronic renal failure (70 +/- 10:1 vs 40 +/- 4:1). It is concluded that there is altered iodine trapping in CRF patients but iodine organification appears to be normal.
对30例接受定期血液透析的患者进行了体外甲状腺功能测试。此外,8例患者(1例尚未进行透析)接受了高氯酸盐释放试验,并测量了131I的唾液与血浆比值,以确定碘摄取或有机化方面的缺陷。与35名健康对照者相比,尿毒症患者的总T4(5.8±0.4 vs 8.6±0.3微克/100毫升)和总T3(81±6 vs 124±5纳克/100毫升)较低,但透析患者的T3RU较高(35.5±0.9 vs 28±0.5%,P<0.01)。TSH水平与对照组无差异。高氯酸盐给药后1小时的放射性碘摄取显著高于对照值(0.6±0.14 vs 0.06±0.04,P<0.05)。同样,慢性肾衰竭患者的131I唾液与血浆比值较高(70±10:1 vs 40±4:1)。结论是,慢性肾衰竭患者存在碘捕获改变,但碘有机化似乎正常。